The Catalyst program accelerates translation of research into products with clinical impact through funding, mentorship, and identification of resources. Catalyst aims to foster academic and industry collaborations as well as enhance education in early translational research and entrepreneurship.
An intramural funding mechanism focused on development of therapeutics, diagnostics, devices and digital health products.
Exploring innovative collaboration models to promote successful translation of research into clinically valuable products.
Industry Partners: MedImmune, Quest Diagnostics, Millipore-Sigma, Sun Pharma, Genentech
UC Center for Accelerated Innovation
A multi-campus funding mechanism for technology development in disease areas of interest to NHLBI and NIDA.
Preclinical CRO Vendor Program
Facilitates access to pre-selected Contract Resesarch Organizations (CROs) for investigators needing expertise in drug and device development.
News and Events
Read about the interesting projects supported by the Catalyst program and stay on top of events related to early translational research. Also, read the latest Catalyst eNewsletter.